From: Cardiovascular disease (CVD): assessment, prediction and policy implications
Years | Original Data | NDGM | Cumulative | RGR | RGR Mean | Dt | Mean Dt |
---|---|---|---|---|---|---|---|
2005 | 28,096 | 28,096 | 28,096 | Â | Â | Â | Â |
2006 | 28,709 | 28,780 | 56,805 | 0.704 | 0.212 | 1.044 | 2.400 |
2007 | 29,283 | 29,338 | 86,088 | 0.416 | Â | 1.571 | Â |
2008 | 29,907 | 29,911 | 115,995 | 0.258 | Â | 1.903 | Â |
2009 | 30,578 | 30,500 | 146,574 | 0.224 | Â | 2.146 | Â |
2010 | 31,216 | 31,104 | 177,790 | 0.183 | Â | 2.338 | Â |
2011 | 31,891 | 31,724 | 209,681 | 0.155 | Â | 2.495 | Â |
2012 | 32,452 | 32,361 | 242,133 | 0.143 | Â | 2.632 | Â |
2013 | 32,895 | 33,015 | 275,029 | 0.127 | Â | 2.754 | Â |
2014 | 33,453 | 33,686 | 308,482 | 0.117 | Â | 2.858 | Â |
2015 | 34,203 | 34,375 | 342,686 | 0.105 | Â | 2.946 | Â |
2016 | 35,107 | 35,083 | 377,793 | 0.068 | Â | 3.021 | Â |
2017 | 35,992 | 35,809 | 413,786 | 0.041 | Â | 3.090 | Â |
2018 | 36,555 | 36,624 | 36,555 | 0.255 | Â | 1.903 | Â |
2019 | 37,321 | 37,652 | 73,876 | 0.324 | Â | 2.014 | Â |
2020 | Â | 38,107 | 111,983 | Â | Â | Â | Â |
2021 | Â | 38,914 | 150,897 | 0.119 | 0.261 | 1.751 | 2.190 |
2022 | Â | 39,742 | 190,640 | 0.234 | Â | 2.146 | Â |
2023 | Â | 40,593 | 231,234 | 0.193 | Â | 2.338 | Â |
2024 | Â | 41,467 | 272,701 | 0.165 | Â | 2.495 | Â |
2025 | Â | 42,363 | 315,065 | 0.244 | Â | 2.628 | Â |
2026 | Â | 43,284 | 358,349 | 0.329 | Â | 2.743 | Â |
2027 | Â | 44,229 | 402,579 | 0.206 | Â | 2.844 | Â |
MAPE % | Â | 1.9% | Â | Â | Â | Â | Â |